Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92 | 311 | 28 | 68 | 46 |
| Receivables | 18 | 16 | 29 | 9 | 9 |
| TOTAL | $328 | $584 | $241 | $375 | $299 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $328 | $584 | $241 | $375 | $299 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21 | 16 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,124 | 4,274 | 4,646 | 4,630 | 4,366 |
| Other current liabilities | 425 | 406 | 411 | 9 | 670 |
| TOTAL | $4,570 | $4,695 | $5,057 | $4,698 | $5,096 |
| Non-Current Liabilities | |||||
| Long Term Debt | 66 | 63 | 61 | N/A | N/A |
| Other Non-Current Liabilities | 1,228 | 1,626 | 357 | 593 | 436 |
| TOTAL | $1,287 | $1,614 | $884 | $593 | $430 |
| Total Liabilities | $5,858 | $6,309 | $5,941 | $5,291 | $5,525 |
| Shareholders' Equity | |||||
| Common Shares | 58,285 | 57,792 | 58,115 | 57,674 | 58,522 |
| Retained earnings | -86,501 | -86,175 | -85,237 | -83,760 | -85,104 |
| Other shareholders' equity | 22,686 | 22,658 | 21,421 | 21,170 | 21,356 |
| TOTAL | $-5,529 | $-5,726 | $-5,700 | $-4,916 | $-5,226 |
| Total Liabilities And Equity | $328 | $584 | $241 | $375 | $299 |